0001144204-14-069949.txt : 20141120
0001144204-14-069949.hdr.sgml : 20141120
20141120093531
ACCESSION NUMBER: 0001144204-14-069949
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141118
FILED AS OF DATE: 20141120
DATE AS OF CHANGE: 20141120
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sevion Therapeutics, Inc.
CENTRAL INDEX KEY: 0001035354
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 841368850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 721 ROUTE 202/206,
STREET 2: SUITE 130
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
BUSINESS PHONE: 908-864-4444
MAIL ADDRESS:
STREET 1: 721 ROUTE 202/206,
STREET 2: SUITE 130
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: SENESCO TECHNOLOGIES INC
DATE OF NAME CHANGE: 19991006
FORMER COMPANY:
FORMER CONFORMED NAME: NAVA LEISURE USA INC
DATE OF NAME CHANGE: 19970310
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Browne Leslie J
CENTRAL INDEX KEY: 0001300293
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31326
FILM NUMBER: 141237718
MAIL ADDRESS:
STREET 1: P.O. BOX 5350
CITY: PRINCETON
STATE: NJ
ZIP: 08543-5350
4
1
form471638_20141120093430-.xml
X0306
4
2014-11-18
0
0001035354
Sevion Therapeutics, Inc.
SVON
0001300293
Browne Leslie J
721 ROUTE 202/206
SUITE 130
BRIDGEWATER
NJ
US 08807
0
1
0
0
President
Common Stock Option (right to buy)
0.83
2014-11-18
4
A
0
42210
0
A
2015-11-18
2024-11-18
Common Stock
42210
82065
D
The options vest in a two-step process. First, options vest based on the attainment of pre-established corporate and individual performance goals. Second, the options that are earned based on the attainment of performance goals will vest as follows: 25% on the first anniversary of the date of grant with the balance vesting at a rate of 1/36 per month thereafter, subject to the executive officer's continued service through each applicable vesting date, provided, however, that pursuant to Dr. Browne's Retention Agreement, such option will fully vest if Dr. Browne's employment is terminated by the Company without cause. No options will vest if the Company's compensation committee has determined that the performance metrics have not been met.
Such option grant was approved by the Company's compensation committee in September 2014 and, consistent with prior practice, was granted on the second business day following the Company's filing of its quarterly report on Form 10-Q for the period ending September 30, 2014.
Leslie J. Browne
2014-11-20